Literature DB >> 19616261

Proteomics and opportunities for clinical translation in urological disease.

Ali R Vaezzadeh1, Hanno Steen, Michael R Freeman, Richard S Lee.   

Abstract

PURPOSE: Proteomics is a rapidly growing new discipline that has the potential to increase and improve the understanding of protein function and interaction in the context of systems biology. As a translational science it has the potential to identify many new therapeutic targets as well as diagnostic and prognostic biomarkers of disease. Proteomics approaches consist of a combination of powerful technologies such as protein/peptide separation, identification and bioinformatic detection, and quantitation based on powerful computational data processing tools. We present an overview of current proteomics technologies, a review of proteomics applications in urology and a perspective on the future of proteomics in clinical medicine.
MATERIALS AND METHODS: A literature search was performed on the basic concepts of proteomics and technologies commonly used in this field. Advantages, challenges and limitations of current proteomics approaches are discussed, and proteomics applications in the field of urology are presented.
RESULTS: The proteomics approaches to answer clinical questions have only recently been introduced. Many different technologies have been used in this field, which is moving from simple description to quantitative clinical applications.
CONCLUSIONS: Proteomics offers new approaches to the study of genitourinary tract diseases, and the potential to identify clinically relevant biomarkers and new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616261      PMCID: PMC4370209          DOI: 10.1016/j.juro.2009.05.001

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  53 in total

1.  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest.

Authors:  C S Spahr; M T Davis; M D McGinley; J H Robinson; E J Bures; J Beierle; J Mort; P L Courchesne; K Chen; R C Wahl; W Yu; R Luethy; S D Patterson
Journal:  Proteomics       Date:  2001-01       Impact factor: 3.984

Review 2.  Top-down proteomics.

Authors:  Neil L Kelleher
Journal:  Anal Chem       Date:  2004-06-01       Impact factor: 6.986

Review 3.  Impact of proteomics on bladder cancer research.

Authors:  Julio E Celis; Irina Gromova; Jose M A Moreira; Teresa Cabezon; Pavel Gromov
Journal:  Pharmacogenomics       Date:  2004-06       Impact factor: 2.533

4.  Exploring the hidden human urinary proteome via ligand library beads.

Authors:  Annalisa Castagna; Daniela Cecconi; Lau Sennels; Juri Rappsilber; Luc Guerrier; Frederic Fortis; Egisto Boschetti; Lee Lomas; Pier Giorgio Righetti
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

Review 5.  Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins.

Authors:  Caterina Temporini; Enrica Calleri; Gabriella Massolini; Gabriele Caccialanza
Journal:  Mass Spectrom Rev       Date:  2008 May-Jun       Impact factor: 10.946

Review 6.  Hybrid mass spectrometers for tandem mass spectrometry.

Authors:  Gary L Glish; David J Burinsky
Journal:  J Am Soc Mass Spectrom       Date:  2007-11-29       Impact factor: 3.109

Review 7.  Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives.

Authors:  Haleem Issaq; Timothy Veenstra
Journal:  Biotechniques       Date:  2008-04       Impact factor: 1.993

8.  Direct analysis of protein complexes using mass spectrometry.

Authors:  A J Link; J Eng; D M Schieltz; E Carmack; G J Mize; D R Morris; B M Garvik; J R Yates
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

9.  Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.

Authors:  Stephane Decramer; Stefan Wittke; Harald Mischak; Petra Zürbig; Michael Walden; François Bouissou; Jean-Loup Bascands; Joost P Schanstra
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

10.  Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation.

Authors:  Richard S Lee; Flavio Monigatti; Mohini Lutchman; Thomas Patterson; Bogdan Budnik; Judith A J Steen; Michael R Freeman; Hanno Steen
Journal:  Proteomics       Date:  2008-03       Impact factor: 3.984

View more
  4 in total

1.  One-step sample concentration, purification, and albumin depletion method for urinary proteomics.

Authors:  Ali R Vaezzadeh; Andrew C Briscoe; Hanno Steen; Richard S Lee
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

2.  Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin.

Authors:  Siti S Abdullah-Soheimi; Boon-Kiong Lim; Onn H Hashim; Adawiyah S Shuib
Journal:  Proteome Sci       Date:  2010-11-17       Impact factor: 2.480

3.  An in-depth comparison of the male pediatric and adult urinary proteomes.

Authors:  John W Froehlich; Ali R Vaezzadeh; Marc Kirchner; Andrew C Briscoe; Oliver Hofmann; Winston Hide; Hanno Steen; Richard S Lee
Journal:  Biochim Biophys Acta       Date:  2013-05-22

4.  Adsorption of urinary proteins on the conventionally used urine collection tubes: possible effects on urinary proteome analysis and prevention of the adsorption by polymer coating.

Authors:  Iwao Kiyokawa; Kazuyuki Sogawa; Keiko Ise; Fumie Iida; Mamoru Satoh; Toshihide Miura; Ryo Kojima; Katsuhiro Katayama; Fumio Nomura
Journal:  Int J Proteomics       Date:  2011-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.